Recent Updates
Recently added Catalysts
TFX

TELEFLEX INCORPORATED AND SUBSIDIARIES Segment Net Revenues Years Ended

Friday, May 16, 2014 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: TELEFLEX INCORPORATED AND SUBSIDIARIES Segment Net Revenues Years Ended December 31, 2011 2012 2013 Unaudited Vascular North America $ 214,822 $ 222,749 $ 231,112 Anesthesia/Respiratory North America 162,833 180,363 228,485 Surgical North America 1

Full Press Release Details

TELEFLEX INCORPORATED AND SUBSIDIARIES
Segment Net Revenues
Years Ended December 31,
2011 2012 2013
Unaudited
Vascular North America $ 214,822 $ 222,749 $ 231,112
Anesthesia/Respiratory North America 162,833 180,363 228,485
Surgical North America 137,808 143,875 146,058
EMEA 525,277 510,248 557,427
Asia 149,585 173,721 207,207
OEM 129,631 140,230 131,173
All Other 172,572 179,823 194,809
Total $ 1,492,528 $ 1,551,009 $ 1,696,271
ShareAdd on Google
Tags: TFX Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: May 16, 2014

Biotech snapshot

Cash runway
$317M liquidity · $0M/mo burn
Low dilution risk
Lead asset
Arterial SealingPhase 3
Hemostasis of Arterial Punctures →